Navigation Links
Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
Date:1/24/2013

health systems," said Ashoka President Diana Wells . "We have found that in tackling health from a systems level, most of our social entrepreneurs are finding ways to 1) deliver unlikely allies to solve the healthcare practitioner shortage  or 2) are innovating new delivery systems which can reach low income populations in both urban and rural areas.  We are excited to partner with Boehringer Ingelheim once again to tap the transformative power of social entrepreneurship and to solve one of the most critical issues that is confronting society today."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing, and marketing novel products of high therapeutic value for human and veterinary medicine.

Social responsibility is a core element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of its global operations. Mutual cooperation and respect, as well as environmental protection and sustainability, are intrinsic values of all of Boehringer Ingelheim's endeavors.

For more information please visit www.boehringer-ingelheim.com

About Ashoka Changemakers

Ashoka Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social
'/>"/>

SOURCE Ashoka Changemakers
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... American Association of Diabetes Educators, American Diabetes ... A. Menarini, Bayer Group, Bayer Healthcare, BioTex, ... Medicare and Medicaid Services ( USA ... Prevention (CDC), Carlyle Group, Cascade Metrix Inc., ... ConvaTec, Constitution Medical Investor, Dexcom, Diabetes UK, ...
(Date:3/1/2015)... 2015  An innovative interventional radiology treatment has ... relief of their headaches, according to research being ... ,s Annual Scientific Meeting . Clinicians at ... York Empire State College in Saratoga Springs used ... blocks to give patients enough ongoing relief that ...
(Date:2/27/2015)... , Feb. 27, 2015 Roughly ... or very confident substituting an interchangeable biosimilar for ... share the same nonproprietary name, according to a ... Pharmacy,s (AMCP,s) Journal of Managed Care & ... about 25 percent of pharmacists would feel as ...
Breaking Medicine Technology:Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2
... , PISCATAWAY, N.J., Dec. 1 ... of hearing instruments, announced its third annual partnership with Quota ... September 2010. , As part of the renewed partnership, Siemens ... hearing instruments to both children and young adults, age 23 ...
... , ... Board: CBPO) (Nasdaq: CBPO ) ("China Biologic," or,the "Company"), one ... Company has received approval to list its,common stock on the NASDAQ ... shares to begin trading on the NASDAQ on,Wednesday, December 2, 2009, ...
Cached Medicine Technology:Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today ... to serve as chief safety officer. In this role, ... Bangladesh and guide remediation efforts in all factories from ... that the Alliance continues to bring world-class expertise to ... workers,” said Alliance Independent Chair Ellen Tauscher. “His role ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... 02, 2015 As residents and ... co-founders, Michael Burns and Carita Weaver, believe in ... working with the Southlake Chamber of Commerce, Carroll ... works recently launched a website for Southlake mayoral ... primary communications tool for Hill’s campaign, the website ...
(Date:3/1/2015)... NY (PRWEB) March 01, 2015 Adults ... seek insurance rates for term or universal policies can ... some of the best life insurance companies for single ... the system at http://quotespros.com/life-insurance.html . , The rate ... search portal are tied to a number of life ...
(Date:3/1/2015)... The number of transvaginal mesh lawsuits ( ... weeks in two New Jersey litigations where attorneys at ... announces. , A Case List updated on February ... proceeding established for products manufactured by Johnson & Johnson's ... when 90 fewer cases had been centralized. Additionally, 1,700 ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4
... lacosamide, developed by U.S firm Schwarz has found to be ... controlled by other drugs - the company said on Monday ... ,The results of the 485-patient study were presented at the ... treated with a 200-mg dose of the drug, lacosamide, had ...
... Study finds that adolescence boys are at higher risk for ... have found that the seeds of hypertension and its health ... lack of exercise, obesity are some of the factors for ... heart damages. ,In the study which began in ...
... can affect children as young as seven years old to ... restricted to// young women alone. ,Anorexia Nervosa is ... the behavior of binging and vomiting. Bulimia is two to ... that can prove to be lethal. ,Anorexic at ...
... blames inappropriate advertising to be the cause of most ... bans and restrictions on// advertising to teens and children. ... Doctor and the lead author of the guidelines, says ... on television alone and increasingly are being exposed to ...
... coordinator, explained how India’s legal stance on homosexuality is actually ... an// infringement of the human rights of homosexual men. ... to book, in cases dealing with sexual abuse of children. ... it may cause a setback to nailing those who commit ...
... World Bank has prepared a report in which it says, a ... is required to fight bird flu in the next 2 to ... at a conference to be held in the West African country ... poultry farmers caught in the front line should be effectively compensated. ...
Cached Medicine News:Health News:Teen Boys At Greater Risk To High Blood Pressure Than Girls 2Health News:From Six to Sixty, Everyone is Prone to Anorexia 2Health News:Extra Funding To Fight Bird Flu 2
... TBR-40 is a small bench style refrigerator (can ... only a minimum number of bags is to ... External cabinet finish is white colorbond steel while ... closing side hinged glass door is key lockable. ...
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
The Testosterone ELISA is intended for the quantitative determination of testosterone concentration in human serum. No special pretreatment of the sample is necessary....
Medicine Products: